in Newswire March 6, 2018

Class Action Claims Pharma Companies Responsible for NAS Due to Opioid Use

by Erin Gilmore

Last Updated on March 6, 2018

Rees et al v. Mckesson Corporation et al

Filed: February 28, 2018 § 3:18cv511

A group of 20 pharmaceutical companies and distributors has been named in a proposed class action lawsuit filed on behalf of a newborn baby who the suit claims suffers from neonatal abstinence syndrome (NAS) as a result of the defendants’ actions.

Last Updated on March 6, 2018 — 4:03 PM

Erin Gilmore

erin@classaction.org

Erin works primarily on ClassAction.org’s newswire, reporting on cases as they happen. She is an honest writer, a faithful friend, and a mediocre bassist.

About ClassAction.org

ClassAction.org is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.